Search filters

Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 99 years
All genders
Interventional
Purpose of this study to find out if the study drug CFZ533, also referred to as iscalimab, is safe and can help others who have Sjögren’s Syndrome (SjS). SjS is an autoimmune disease in which the body’s defense system attacks moisture-producing glands, causing symptoms of extensive dryness (for example, dry …
25 years - 65 years
All genders
Interventional
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
99 years or below
All genders
Blood is an easily accessible source of tumor cell free (cf) DNA. Both normal and malignant cells shed DNA into the circulation, and advanced genomics technologies can analyze tumor cfDNA, making blood a source of real-time genomic tumor profiling. For ccRCC patients, peripheral blood will be obtained as part of …
99 years or below
All genders
The purpose of this study is to see if niraparib added to a standard treatment (abiraterone acetate and prednisone) will work better than abiraterone acetate and prednisone alone in treating men with metastatic prostate cancer with specific genetic changes. Eligible subjects will be men with metastatic prostate cancer.
 A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas
18 years - 99 years
All genders
Phase 3
This study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection surgery. Potential patients who sign informed consent will be screened for eligibility before receiving an oral solution of Gleolan 3 hours prior to …
19 years - 40 years
Female
Interventional
This study evaluates the effectiveness of the FemaSeed device for intrauterine insemination (IUI). Eligible subjects are infertile females who meet clinical eligibility IUI per Penn Fertility Care practice standards. After their eligibility is confirmed, participants may attempt up to 6 cycles of IUI with the study device during the duration …
 Evaluating Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis
18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study is to evaluate how well the study drug (Navitoclax) works in combination with ruxolitinib when compared to best available therapy in subjects with Relapsed/Refractory Myelofibrosis.
99 years or below
All genders
Phase 2
Interventional
The purpose of this study is to determine the safety and efficacy of mitapivat in patients with sickle cell disease. Patients will be randomly assigned (like flipping a coin) in a 1:1:1 ratio to receive 50mg mitapivat, 100mg mitapivat or matched placebo for twice-daily oral administration. This means that you …
99 years or below
All genders
Interventional
The purpose of this study is to test the use of Tecovirimat (TPOXX ) for Treatment of Human Orthopoxvirus Infections. Tecovirimat (also known as TPOXX or ST-246) is a drug that may help to treat infections caused by pox viruses and reactions to the smallpox vaccine. Eligible Participants: • Have …
18 years - 99 years
All genders
Phase 1
Interventional
The main purpose of this research is to try and find a better way to treat cancer. Specifically, this research will study how participants tolerate and might benefit from combining a special diet that is low in carbohydrates and high in fat with a drug intended to treat cancer (called …
451 - 460 of 1202